Clinical Trial VICCPED0921


Expanded Access of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD.

Principal Investigator(s)

Jennifer Domm


  • Protocol No. VICCPED0921
  • Open Date: 05/01/2009
  • Staging: Phase I
  • Age Group: Children
  • Scope: National
  • Objective: Allow pediatric patients who have failed to respond to steroid treatment for acute GVHD expanded access to Prochymal.
  • Disease Sites: Pediatrics; Leukemia
  • Therapies: Molecular Targeted Agents / Immunotherapy / Biologics
  • Drugs: Prochymal
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT00759018
  • Secondary Protocol No: 275



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.